Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cyclacel Pharmaceuticals Inc CYCC

Alternate Symbol(s):  CYCCP

Healthcare Biotechnology
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cancer medicines based on cell cycle, epigenetics and mitosis biology. Its epigenetic/anti-mitotic program is evaluating plogo, a Polo-like kinase 1 (PLK1) inhibitor, in solid tumors and hematological malignancies. PLK1 is a serine/threonine kinase with a central role in cell... see more

Bullboard (NDAQ:CYCC)

View:
1 2 Next
User Avatar Image
(103)
•••
  • IseneschalX
Post by Iseneschalon Jan 03, 2025 3:06pm

CYCC....bot the L.O.D and sold the rip

Thanks Mr. M Cheers !
27
User Avatar Image
(103)
•••
  • IseneschalX
Post by Iseneschalon Jan 03, 2025 11:36am

CYCC...NR re: Conv deb / Lazar investor

Looks like it's Fryday to all the Chasers
42
User Avatar Image
(10)
•••
  • MikeTesterX
Post by MikeTesteron Aug 02, 2024 3:24am

Cyclacel Pharmaceuticals (CYCC): A Promising Oncology Biotec

https://beyondspx.com/2024/08/01/cyclacel-pharmaceuticals-cycc-a-promising-oncology-biotech-with-exciting-pipeline-developments/
61
User Avatar Image
(103)
•••
  • IseneschalX
Post by Iseneschalon Apr 25, 2024 1:58pm

CYCC.....FOMO's wanted....sign up to the Chasers list

JMHO
65
User Avatar Image
(103)
•••
  • IseneschalX
Post by Iseneschalon Apr 25, 2024 1:57pm

CYCC.....zero volume at the low

No the bottom feeders are offing their paper
54
User Avatar Image
(103)
•••
  • IseneschalX
Post by Iseneschalon Apr 25, 2024 1:26pm

CYCC....N.L.O.D $1.41

Yesterdays vol & price action was just a Pump & Dump by none other than the Infamous Mr. Maggot !!!!!
68
User Avatar Image
(103)
•••
  • IseneschalX
Post by Iseneschalon Apr 25, 2024 12:22pm

CYCC....N.L.O.D.....$1.59

Ya have to be ready for these RS thinners throwing everyone a "curveball" Market Makers are throwing a few of these lately
85
User Avatar Image
(103)
•••
  • IseneschalX
Post by Iseneschalon Apr 25, 2024 9:45am

CYCC....I am totally rid of this

sec.gov/Archives/edgar/data/1130166/000110465924051334/tm249520d5_s1.htm
55
User Avatar Image
(103)
•••
  • IseneschalX
Post by Iseneschalon Mar 27, 2024 2:15pm

CYCC....still watching this Mr. maggot ; )

Whack that bid.... need some cheap paper ; ) Sub $1.75 would be nice. Thanks for your manipulative endeavours
58
User Avatar Image
(103)
•••
  • IseneschalX
Comment by Iseneschalon Mar 26, 2024 3:10pm

RE:CYCC....trading by appt only....Lol

Seems to me Mr. M can intercept any shares from weak hands selling It's not a level playing field...hehe
105
1 2 Next
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities